Skip to main content
OpenTrials

Clinical trial condition

Phosphorus Metabolism Disorders

Explore clinical trials studying Phosphorus Metabolism Disorders. Study availability and eligibility vary by location and protocol.

188 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Phosphorus Metabolism Disorders trial results

Completed

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

NCT02163577

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Indiana University Hospital Indianapolis, Indiana, United States
  • Shriners Hospital for Children St Louis, Missouri, United States
View Trial Details
Completed

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

NCT04456803

Conditions
Chronic Disease, Disease Attributes, ESRD, +16 more
Locations
  • The first affiliated hospital of Baotou medical college Baotou, China
  • Beijing Tongren Hospital Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • The Second Xiangya Hospital of Central South University Changsha, China
View all 20 locations
View Trial Details

Related conditions